[MYGN] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
12-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 25.84%
YoY- 84.05%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 188,765 182,924 204,060 202,467 174,116 156,472 149,140 17.05%
PBT 52,550 57,343 84,144 83,827 67,228 59,241 56,985 -5.27%
Tax 18,921 20,573 33,784 28,362 23,153 21,349 21,949 -9.44%
NP 33,629 36,770 50,360 55,465 44,075 37,892 35,036 -2.70%
Tax Rate -36.01% -35.88% -40.15% -33.83% -34.44% -36.04% -38.52% -
Total Cost 155,136 146,154 153,700 147,002 130,041 118,580 114,104 22.79%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 17.82 20.10 24.68 27.39 25.31 24.22 23.49 -16.86%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS 0.45 0.50 0.67 0.70 0.55 0.47 0.43 3.08%
EPS Diluted 0.43 0.48 0.66 0.68 0.53 0.46 0.42 1.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.